LB Pharmaceuticals Inc (LBRX) stock
LBRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$40.30−2.69 (-6.26%)
Close on Nov 17, 2026Market cap $1.30BP/E –Yield –
LB Pharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
LB Pharmaceuticals's enterprise value was $957.43M on Nov 11, 2026, against $135.57M a year earlier.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $957.43M | +285.0% |
| 2025 | Dec 31, 2025 | $248.66M | – |
See a number that looks wrong?